Congress locks vaccine decisions into law, requires public disclosure of scientific reasoning.

What it does

This bill codifies the Advisory Committee on Immunization Practices (ACIP) into federal law, establishing its structure, duties, and governance. It requires the CDC Director to adopt ACIP vaccine recommendations unless they lack scientific support, and mandates public disclosure of any rejection with scientific justification within 48 hours to Congress. It also adds a scientific-evidence standard to the National Vaccine Injury Compensation Program's vaccine table modifications.

Why we flagged it

The bill's core function is to codify an existing advisory committee into law and establish transparent, evidence-based procedures for vaccine recommendations. It is fundamentally a governance and accountability mechanism, not a deregulation, subsidy, or carve-out.

What the text implies

• The 48-hour notification requirement to Congress may create political pressure on CDC Director decisions, potentially slowing emergency vaccine responses if Congress demands explanation before deployment.
• Codification locks ACIP structure into statute, making future procedural changes require legislative action rather than administrative adjustment, reducing flexibility in response to evolving public health needs.
• The 'preponderance of best available peer-reviewed scientific evidence' standard is legally defined but may invite litigation over what constitutes 'best available' evidence, particularly during emerging disease outbreaks.
• Stakeholder organization list (subsection j) includes pharmaceutical industry representatives (Biotechnology Innovation Organization, Pharmaceutical Research and Manufacturers of America), creating potential conflicts of interest in vaccine recommendations.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill strengthens public accountability in vaccine policy by codifying ACIP, requiring evidence-based decisions, and mandating transparent disclosure of any departures from scientific recommendations to Congress and the public. Citizens gain enforceable procedural protections and visibility into the scientific reasoning behind vaccine recommendations.

Named in the bill

Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), National Institutes of Health (NIH), Health Resources and Services Administration (HRSA), Indian Health Service (IHS), Vaccines for Children Program, National Vaccine Injury Compensation Program, Pharmaceutical Research and Manufacturers of America, Biotechnology Innovation Organization — and 2 more

Where it stands

9 cosponsors: 9 Democrats.

• Dec 3, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Dec 3, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
• Mar 19, 2026 — Hearing held · Congress.gov: “Committee on Health, Education, Labor, and Pensions. Hearings held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $410,000 in lobbying spend. A filing names 166 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

John Hickenlooper, the sponsor, reported $975,352 in PAC receipts in the 2026 cycle.

• American Federation of Teachers — $410,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.